Preclinical pharmacology of KB408, an HSV-1-based gene therapy vector, for the treatment of alpha-1 antitrypsin deficiencyS. Artusi,P. Zhang, M. J. Duermeyer, T. Parry,S. KrishnanHUMAN GENE THERAPY（2021）引用 1|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
